Max Drawdown (5Y) Chart

Historical Max Drawdown (5Y) Data

View and export this data back to 2014. Start Trial.
Date Value
September 30, 2026 99.94%
August 31, 2026 99.94%
July 31, 2026 99.94%
June 30, 2026 99.94%
May 31, 2026 99.94%
April 30, 2026 99.94%
March 31, 2026 99.94%
February 28, 2026 99.94%
January 31, 2026 99.93%
December 31, 2025 99.92%
November 30, 2025 99.92%
October 31, 2025 99.89%
September 30, 2025 99.89%
August 31, 2025 99.89%
July 31, 2025 99.89%
June 30, 2025 99.89%
May 31, 2025 99.89%
April 30, 2025 99.89%
March 31, 2025 99.87%
February 28, 2025 99.80%
January 31, 2025 99.79%
December 31, 2024 99.79%
November 30, 2024 99.79%
October 31, 2024 99.79%
September 30, 2024 99.79%
Date Value
August 31, 2024 99.79%
July 31, 2024 99.79%
June 30, 2024 99.79%
May 31, 2024 99.79%
April 30, 2024 99.79%
March 31, 2024 99.79%
February 29, 2024 99.79%
January 31, 2024 99.79%
December 31, 2023 99.79%
November 30, 2023 99.79%
October 31, 2023 99.79%
September 30, 2023 99.74%
August 31, 2023 99.64%
July 31, 2023 99.50%
June 30, 2023 98.70%
May 31, 2023 98.46%
April 30, 2023 98.39%
March 31, 2023 98.39%
February 28, 2023 98.39%
January 31, 2023 98.39%
December 31, 2022 98.39%
November 30, 2022 98.37%
October 31, 2022 98.27%
September 30, 2022 98.27%
August 31, 2022 97.72%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
BioLineRx Ltd. 98.88%
XTL Biopharmaceuticals Ltd. 90.10%
Kamada Ltd. 67.69%
Can-Fite BioPharma Ltd. 99.50%
Revium Recovery, Inc. 98.64%